Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0037315 (
sleep apnea
)
8,000
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oxyhemogloblin affinity (P50 at pH 7.4, PaCO2 = 40 mm Hg, temperature = 37 degrees C) and 2,3-
DPG
concentration were assessed in 15 nonsmokers (14 men and one woman 46 to 63 yr of age) with
sleep apnea syndrome
(
SAS
) and in 10 normal subjects (eight men and two women 22 to 48 yr of age). In patients with
SAS
, mean nocturnal apnea index was 46 +/- 20/h, and mean nocturnal SO2 was 86 +/- 6% versus 94.6 +/- 1.8% during the daytime. Daytime mean P50 of the patients was 28.5 +/- 1.2 mm Hg versus 27.1 +/- 0.3 mm Hg in the normal subjects (p less than 0.05). Daytime mean 2.3-
DPG
was 1.23 +/- 0.25 moles
DPG
/mole hemoglobin versus 0.80 +/- 0.15 (p less than 0.05). Significant correlations were found in patients between P50 and mean nocturnal SO2 (r = -0.62, p less than 0.01) and between P50 and 2,3-
DPG
(r = 0.68, p less than 0.01). The measurements were repeated in five patients after surgical or positive-pressure treatment. P50 and 2,3-
DPG
both decreased and returned to normal values. In conclusion, the oxyhemoglobin dissociation curve is shifted to the right in patients with
SAS
and there is an increase in 2,3-
DPG
. These could be protective mechanisms against the development of polycythemia, pulmonary hypertension, and cor pulmonale.
...
PMID:Decreased oxyhemoglobin affinity in patients with sleep apnea syndrome. 190 Apr 1